Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Thamizan K Tucker, Alison J Ritter, Claire Maher & Henry Jackson. (2004) Naltrexone maintenance for heroin dependence: uptake, attrition and retention. Drug and Alcohol Review 23:3, pages 299-309.
Read now
Read now
Roger D. Weiss, Margaret L. Griffin, Cathryn Hufford, Larry R. Muenz, Lisa M. Najavits, Stephanie B. Jansson, Julia Kogan & Heather J. Thompson. (1997) Early Prediction of Initiation of Abstinence from Cocaine: Use of a Craving Questionnaire. American Journal on Addictions 6:3, pages 224-231.
Read now
Read now
Gantt Galloway & Gregory Hayner. (1993) Haight-Ashbury Free Clinics' Drug Detoxification Protocols — Part 2: Opioid Blockade. Journal of Psychoactive Drugs 25:3, pages 251-252.
Read now
Read now
Macdonald J. Christie & Anna I. Harvey. (1993) Pharmacological options for management of opioid dependence. Drug and Alcohol Review 12:1, pages 71-80.
Read now
Read now
Thomas R. Kosten. (1992) Can Cocaine Craving Be a Medication Development Outcome?: Drug Craving and Relapse in Opioid and Cocaine Dependence. American Journal on Addictions 1:3, pages 230-239.
Read now
Read now
Thomas R. Kosten & Herbert D. Kleber. (1984) Strategies to Improve Compliance with Narcotic Antagonists. The American Journal of Drug and Alcohol Abuse 10:2, pages 249-266.
Read now
Read now
Articles from other publishers (28)
Icro Maremmani, Maurice Dematteis, Edward J. Gorzelanczyk, Alessandro Mugelli, Stephan Walcher & Marta Torrens. (2023) Long-Acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. Journal of Clinical Medicine 12:17, pages 5575.
Crossref
Crossref
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
1
37
.
Bethea A. Kleykamp, Marta De Santis, Robert H. Dworkin, Andrew S. Huhn, Kyle M. Kampman, Ivan D. Montoya, Kenzie L. Preston, Tanya Ramey, Shannon M. Smith, Dennis C. Turk, Robert Walsh, Roger D. Weiss & Eric C. Strain. (2019) Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence 205, pages 107639.
Crossref
Crossref
John Strang, Michael Kelleher, Soraya Mayet, Ed Day, Jennifer Hellier, Sarah Byford, Caroline Murphy, Blair McLennan, James Shearer, Elizabeth Ryan & John Marsden. (2019) Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT. Health Technology Assessment 23:3, pages 1-72.
Crossref
Crossref
Nikolaj Kunøe, Arild Opheim, Kristin Klemmetsby Solli, Zhanna Gaulen, Kamni Sharma-Haase, Zill-e-Huma Latif & Lars Tanum. (2016) Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX). BMC Pharmacology and Toxicology 17:1.
Crossref
Crossref
Shih‐Ku Lin. (2014) Pharmacological means of reducing human drug dependence: a selective and narrative review of the clinical literature. British Journal of Clinical Pharmacology 77:2, pages 242-252.
Crossref
Crossref
Silvia Minozzi, Laura Amato, Simona Vecchi, Marina Davoli, Ursula Kirchmayer & Annette Verster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Gary K. Hulse, Hanh T.T. Ngo & Robert J. Tait. (2010) Risk Factors for Craving and Relapse in Heroin Users Treated with Oral or Implant Naltrexone. Biological Psychiatry 68:3, pages 296-302.
Crossref
Crossref
AS Reece. (2007) Psychosocial and treatment correlates of opiate free success in a clinical review of a naltrexone implant program. Substance Abuse Treatment, Prevention, and Policy 2:1.
Crossref
Crossref
Boukje A. G. Dijkstra, Cor A. J. De Jong, Sarah M. Bluschke, Paul F. M. Krabbe & Cees P. F. Van Der Staak. (2007) CLINICAL STUDY: Does naltrexone affect craving in abstinent opioid‐dependent patients?. Addiction Biology 12:2, pages 176-182.
Crossref
Crossref
Maria A. Sullivan, Suzanne K. Vosburg & Sandra D. Comer. (2006) Depot naltrexone: antagonism of the reinforcing, subjective, and physiological effects of heroin. Psychopharmacology 189:1, pages 37-46.
Crossref
Crossref
Icro Maremmani, Giulio Perugi, Matteo Pacini & Hagop S. Akiskal. (2006) Toward a unitary perspective on the bipolar spectrum and substance abuse: Opiate addiction as a paradigm. Journal of Affective Disorders 93:1-3, pages 1-12.
Crossref
Crossref
Silvia Minozzi, Laura Amato, Simona Vecchi, Marina Davoli, Ursula Kirchmayer & Annette Verster. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Icro Maremmani, Matteo Pacini, Giulio Perugi & Hagop S Akiskal. (2004) Addiction and the Bipolar Spectrum. Addictive Disorders & Their Treatment 3:4, pages 156-164.
Crossref
Crossref
Evgeny M Krupitsky, Edwin E Zvartau, Dimitry V Masalov, Marina V Tsoi, Andrey M Burakov, Valentina Y Egorova, Tatyana Y Didenko, Tatyana N Romanova, Eva B Ivanova, Anton Y Bespalov, Elena V Verbitskaya, Nikolai G Neznanov, Alexandr Y Grinenko, Charles P O'Brien & George E Woody. (2004) Naltrexone for heroin dependence treatment in St. Petersburg, Russia. Journal of Substance Abuse Treatment 26:4, pages 285-294.
Crossref
Crossref
U Kirchmayer, M Davoli & A Verster. 1996. The Cochrane Database of Systematic Reviews. The Cochrane Database of Systematic Reviews.
Ursula Kirchmayer, Marina Davoli, Annette D. Verster, Laura Amato, Arica Ferri & Carlo A. Perucci. (2002) A systematic review on the efficacy of naltrexone maintenance treatment in opioid dependence. Addiction 97:10, pages 1241-1249.
Crossref
Crossref
Agustín Madoz-Gúrpide, Enriqueta Ochoa & Enrique Baca-García. (2002) Revisión de la efectividad de los programas de mantenimiento con naltrexona: parámetros de evaluación, perfiles de indicación y factores asociados. Medicina Clínica 119:9, pages 351-355.
Crossref
Crossref
THAMIZAN K TUCKER & ALISON J. RITTER. (2009) Naltrexone in the treatment of heroin dependence: a literature review. Drug and Alcohol Review 19:1, pages 73-82.
Crossref
Crossref
Lev Langerman, Ruth A Steingart, Anatoly Margolis & Joseph Yanai. (1999) A method of reducing the opioid withdrawal intensity using progressively increasing doses of naloxone. Journal of Pharmacological and Toxicological Methods 42:3, pages 115-119.
Crossref
Crossref
Roger D. Weiss, Margaret L. Griffin, Cathryn Hufford, Larry R. Muenz, Lisa M. Najavits, Stephanie B. Jansson, Julia Kogan & Heather J. Thompson. (2010) Early Prediction of Initiation of Abstinence From Cocaine. The American Journal on Addictions 6:3, pages 224-231.
Crossref
Crossref
Emi N. Shufman, Shai Porat, Eliezer Witztum, Dan Gandacu, Rachel Bar-Hamburger & Yigal Ginath. (1994) The efficacy of naltrexone in preventing reabuse of heroin after detoxification. Biological Psychiatry 35:12, pages 935-945.
Crossref
Crossref
Thomas R. Kosten. (2010) Can Cocaine Craving Be a Medication Development Outcome?. The American Journal on Addictions 1:3, pages 230-239.
Crossref
Crossref
Sally K. Guthrie. (2016) Pharmacologic Interventions for the Treatment of Opioid Dependence and Withdrawal. DICP 24:7-8, pages 721-734.
Crossref
Crossref
Charles P. O’Brien & George E. Woody. 1986. Research Advances in Alcohol and Drug Problems. Research Advances in Alcohol and Drug Problems
245
260
.
P.C. McLean & Patricia Casey. 1982. Drugs in Psychiatric Practice. Drugs in Psychiatric Practice
321
351
.
Raymond F. Anton, Izola Hogan, Behnaz Jalali, Charles E. Riordan & Herbert D. Kleber. (1981) Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug and Alcohol Dependence 8:2, pages 157-168.
Crossref
Crossref
Barbara A. Judson, Thomas M. Carney & Avram Goldstein. (1981) Naltrexone treatment of heroin addiction: Efficacy and safety in a double-blind dosage comparison. Drug and Alcohol Dependence 7:4, pages 325-346.
Crossref
Crossref